TMCnet News
Research and Markets: Subcutaneous Biologics: Products, Technologies and Delivery Systems Markets 2015 - 2025Research and Markets (http://www.researchandmarkets.com/research/phtzrg/subcutaneous) has announced the addition of the "Subcutaneous Biologics Market, 2015 - 2025" report to their offering. The 'Subcutaneous Biologics: Products, Technologies and Delivery Systems' report provides an extensive study of the rapidly growing market of subcutaneous biologic drugs. It is an emerging area that is gaining substantial attention from researchers and manufacturers across the globe. Subcutaneous delivery provides numerous advantages over other routes of delivery. Some of the major benefits include reduction in time spent in drug administration, reduced patient time at healthcare facilities, decreased healthcare costs and improved therapy compliance. The utility of viscous biologics in the treatment of chronic diseases, the increasing trend of self-medication and requirement of high concentration subcutaneous formulation of biologics are some of the driving factors behind the market's evolution. The study not only provides an in-depth analysis of pipeline and marketed subcutaneous biologic drug candidates but also includes a detailed discussion on the formulation and delivery aspects associated with such biological macromolecules. In addition, the advancing trend of transition from intravenous to subcutaneous and the fundamental challenge of formulation of biologics into subcutaneous format highlight the crucial role of technology developers in this field. The requirement of suitable delivery systems for subcutaneous administration also presents immense growth prospects for device maufacturing firms which are working aggressively to provide a diverse range of self-injection devices. In fact, one of the key objectives of the report is to identify the future potential of the industry for these stakeholders. In addition to the market forecast for subcutaneous biologic drugs, we have also provided a ten year forecast of the subcutaneous delivery systems including prefilled syringes, drug reconstitution systems and bolus injectors. The base year for the report is 2014. The research, analysis and insights presented in this report is backed by a deep understanding of key insights gathered both from primary and secondary research. Highlights:
Key Topics Covered: 1. Preface 2. Executive Summary 3. Introduction 4. Subcutaneous Biologics Market 5. Technologies For Subcutaneous Formulation Of Biologics 6. Drug Delivery Systems For Subcutaneous Delivery Of Biologics 7. Market Sizing And Forecast 8. Case Studies: Technology Developers 9. Swot Analysis 10. Interview Transcripts 11. Conclusion 12. Appendix 1: Tabulated Data 13. Appendix 2: List Of Companies For more information visit http://www.researchandmarkets.com/research/phtzrg/subcutaneous
|